Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/24/20 → 10/31/22 |
Funding
- Biomedical Advanced Research and Development Authority: $75,559.06
COVID-19: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19
- Fries, Bettina (PI)
- Marcos Raymundo, Luis (CoPI)
Project: Research